Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Jaeger

Showing results (11-20 of 60) with videos related to

Pageof 6
Sort By:
BMC Cancer|August 2, 2017
Randomized controlled trial of S-1 maintenance therapy in metastatic esophagogastric cancer - the multinational MATEO studyGeorg-Martin Haag, Gertraud Stocker, Julia Quidde, et al.
Anticancer Research|July 31, 2013
Nab-Paclitaxel monotherapy as a treatment of patients with metastatic breast cancer in routine clinical practiceJulia Aigner, Frederik Marmé, Katharina Smetanay, et al.
Case Reports in Oncology|April 30, 2013
Posterior reversible leukoencephalopathy syndrome associated with pazopanibRobert Foerster, Thomas Welzel, Juergen Debus, et al.
Environmental Monitoring and Assessment|October 15, 2015
Mapping the optimal forest road network based on the multicriteria evaluation technique: the case study of Mediterranean Island of Thassos in GreeceStergios Tampekis, Stavros Sakellariou, Fani Samara, et al.
Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research|July 7, 2007
Protein S100 as prognostic marker for gastrointestinal stromal tumors: a clinicopathological risk factor analysisDaniel Perez, Nicoloas Demartines, Karin Meier, et al.
Oncology|October 19, 2012
Diarrhea is a positive outcome predictor for sorafenib treatment of advanced hepatocellular carcinomaRonald Koschny, Daniel Gotthardt, Christiane Koehler, et al.
Plos One|December 14, 2011
Automatic tumor-stroma separation in fluorescence TMAs enables the quantitative high-throughput analysis of multiple cancer biomarkersBernd Lahrmann, Niels Halama, Hans-Peter Sinn, et al.
Plos One|November 20, 2009
Estimation of immune cell densities in immune cell conglomerates: an approach for high-throughput quantificationNiels Halama, Inka Zoernig, Anna Spille, et al.
International Journal of Radiation Oncology, Biology, Physics|March 24, 2009
Neoadjuvant treatment does not influence perioperative outcome in rectal cancer surgeryAlexis Ulrich, Jürgen Weitz, Matthias Slodczyk, et al.
Cancer Research|July 12, 2019
Recent Advances Targeting CCR5 for Cancer and Its Role in Immuno-OncologyXuanmao Jiao, Omar Nawab, Tejal Patel, et al.
Pageof 6

Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
BMC Cancer|August 2, 2017
Randomized controlled trial of S-1 maintenance therapy in metastatic esophagogastric cancer - the multinational MATEO studyGeorg-Martin Haag, Gertraud Stocker, Julia Quidde, et al.
Anticancer Research|July 31, 2013
Nab-Paclitaxel monotherapy as a treatment of patients with metastatic breast cancer in routine clinical practiceJulia Aigner, Frederik Marmé, Katharina Smetanay, et al.
Case Reports in Oncology|April 30, 2013
Posterior reversible leukoencephalopathy syndrome associated with pazopanibRobert Foerster, Thomas Welzel, Juergen Debus, et al.
Environmental Monitoring and Assessment|October 15, 2015
Mapping the optimal forest road network based on the multicriteria evaluation technique: the case study of Mediterranean Island of Thassos in GreeceStergios Tampekis, Stavros Sakellariou, Fani Samara, et al.
Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research|July 7, 2007
Protein S100 as prognostic marker for gastrointestinal stromal tumors: a clinicopathological risk factor analysisDaniel Perez, Nicoloas Demartines, Karin Meier, et al.
Oncology|October 19, 2012
Diarrhea is a positive outcome predictor for sorafenib treatment of advanced hepatocellular carcinomaRonald Koschny, Daniel Gotthardt, Christiane Koehler, et al.
Plos One|December 14, 2011
Automatic tumor-stroma separation in fluorescence TMAs enables the quantitative high-throughput analysis of multiple cancer biomarkersBernd Lahrmann, Niels Halama, Hans-Peter Sinn, et al.
Plos One|November 20, 2009
Estimation of immune cell densities in immune cell conglomerates: an approach for high-throughput quantificationNiels Halama, Inka Zoernig, Anna Spille, et al.
International Journal of Radiation Oncology, Biology, Physics|March 24, 2009
Neoadjuvant treatment does not influence perioperative outcome in rectal cancer surgeryAlexis Ulrich, Jürgen Weitz, Matthias Slodczyk, et al.
Cancer Research|July 12, 2019
Recent Advances Targeting CCR5 for Cancer and Its Role in Immuno-OncologyXuanmao Jiao, Omar Nawab, Tejal Patel, et al.
Pageof 6